
    
      Healthy adults < 65 years of age who received Adacel vaccine 10 years previously will be
      randomized to receive either Adacel or TENIVAC (Td Adsorbed) vaccine. They will be assessed
      for immunogenicity at baseline and post-vaccination. Safety data will be collected for 6
      months following vaccination.
    
  